Carol Mathews is a Psychiatry physician. ClinicalTrials.gov lists 4 registered studies matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Research metrics aren't shown for this record. Either we found no confident publication match for this name, or more than one physician shares the matched author record. We'd rather show nothing than someone else's numbers. Why? →
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
1600 SW Archer Rd
Box 100256
Gainesville, FL 326100256
Telephone
352-265-7981Registry record last updated 31 Jul 2015.
Clinical trials
- Biomarker Changes and Anxiolytic Effects-Phase 2
Sponsor: University of Florida
- A Phased Clinical Trial of Dietary Supplemental Kava: Kava Pharmacokinetics
Sponsor: University of Florida
- Integrating Pharmacogenomic Testing Into a Child Psychiatry Clinic
Sponsor: University of Florida
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Medicare prescribing footprint (2023)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Nervous system
100%Atypical Antipsychotic42.2%Quetiapine Fumarate67%Risperidone33%Part D<11 patientsSSRI26.5%Sertraline Hcl52%Trazodone Hcl48%Part D<11 patients+ 2 more classes in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
5 NIH research awards on record, funded 2015–2026 per NIH RePORTER. The latest:
- Visual perception and attention in the obsessive-compulsive/anxiety spectrum: Neurophysiological characterization, predictive value, and computational modeling
University of Florida
FY2026$646,996R01MH135426 - The EEG spectrum as a marker of severity, burden, and psychiatric diagnosis
University of Florida
FY2026$151,761R03MH143166 - Visual perception and attention in the obsessive-compulsive/anxiety spectrum: Neurophysiological characterization, predictive value, and computational modeling
University of Florida
FY2025$644,708R01MH135426
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Similar KOLs
Other experts from the same institution or the same specialty.
Philip Scheltens
Inserm
Rafael Tabarés‐Seisdedos
Universitat de València
Nick C. Fox
UK Dementia Research Institute
Perminder S. Sachdev
Department of Health and Aged Care
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”